|
|
Volumn 293, Issue 5527, 2001, Pages 58-59
|
|
Drugs on target
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA CYCLODEXTRIN;
CARMUSTINE;
DNA;
HEPARIN;
HUMAN GROWTH HORMONE;
INSULIN;
INTERFERON;
LOW DENSITY LIPOPROTEIN;
MACROGOL;
METHYLPHENIDATE;
POLYETHYLENEIMINE;
POLYLYSINE;
BETA CYCLODEXTRIN DERIVATIVE;
CYCLODEXTRIN;
AEROSOL;
ATTENTION DEFICIT DISORDER;
BRAIN CANCER;
COMPLEX FORMATION;
CONTROLLED DRUG RELEASE;
DEVICE;
DRUG ABSORPTION;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TRANSPORT;
GENE THERAPY;
HUMAN;
IMPLANT;
PARTICLE SIZE;
PITUITARY DWARFISM;
PRIORITY JOURNAL;
SHORT SURVEY;
SUSTAINED RELEASE PREPARATION;
ANTIBODY SPECIFICITY;
ARTICLE;
DELAYED RELEASE FORMULATION;
DNA MICROARRAY;
INHALATIONAL DRUG ADMINISTRATION;
METABOLISM;
METHODOLOGY;
ORAL DRUG ADMINISTRATION;
ADMINISTRATION, INHALATION;
ADMINISTRATION, ORAL;
BETA-CYCLODEXTRINS;
CYCLODEXTRINS;
DELAYED-ACTION PREPARATIONS;
DNA;
DRUG DELIVERY SYSTEMS;
GENE THERAPY;
HUMANS;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
ORGAN SPECIFICITY;
|
|
EID: 0035816535
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1063273 Document Type: Short Survey |
|
Times cited : (548)
|
|
References (10)
|
